April 15th, 2017
•We describe the use of a phenotypic fluorescence-based neuraminidase inhibition assay to assess the susceptibility of influenza A and B viruses to the neuraminidase inhibitor class of antivirals.
Tags
Related Videos
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice (Video) | JoVE
Assays for the Identification of Novel Antivirals against Bluetongue Virus (Video) | JoVE
Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System (Video) | JoVE
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses (Video) | JoVE
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity Video (Video) | JoVE
The Use of Flow Cytometry to Assess the State of Chromatin in T Cells Video (Video) | JoVE
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B Video (Video) | JoVE
Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay Video (Video) | JoVE
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies Video (Video) | JoVE
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved